Dr. Robert Mittendorff is a General Partner and Global Head of Healthcare at B Capital, where he leads venture and growth investments in category defining healthcare companies. At B Capital, he has invested in and serves on the board of companies such as CapitalRx, Carlsmed, Nalu Medical, Lively, Triumvira, Atomwise and Carrick, among others.

Previously, he spent nearly a decade at Norwest Venture Partners as Partner and Co-Head of Healthcare. He has been involved in investments and associated exits with public equity value or acquisition value exceeding $10B. He is a board-certified emergency physician and former public company operating executive with experience spanning investing, complex business development transactions, the leadership of clinical advisory boards, product development, clinical trials, commercial activities and clinical services management. He is a Fellow of the American Academy of Emergency Medicine (FAAEM).

He has extensive board experience as both a director and observer at companies including Impel Neuropharma, Avalyn Pharma, Qventus, VisitPay, TigerConnect, Neocis, Talkspace, Omada, Route92, Silk Road Medical (SILK), iCardiac (acq. by eResearch), Telcare (acq. by BioTelemetry, Intersect ENT (Nasdaq: XENT) and iRhythm Technologies (Nasdaq: IRTC).

Robert was involved with the initial investments in Misfit Wearables (acquired by Fossil) and Health Catalyst (HCAT), and led seed investments in Myome, Excision Biosciences and Clerio.

Dr. Mittendorff was co-chair of the Digital Healthcare Innovation Summit and a member of the Leadership Fellows at Johns Hopkins. Prior to his career in venture capital, Dr. Mittendorff was an executive at Hansen Medical Inc., where he launched the Magellan & Sensei X robots and led the Company’s partnerships with GE, Siemens, Philips and St. Jude Medical.

He has worked in portfolio strategy at Merck, as a management consultant at BCG and as an emergency physician at Kaiser Permanente. He earned an MD from Harvard Medical School, trained in Emergency Medicine at Stanford University and earned an MBA from Harvard Business School and a BS in biomedical engineering from Johns Hopkins University. He has completed fellowships with Howard Hughes, MIT and HBS. He is based in San Francisco.